Markets /Healthcare /LCI Lannett Company, Inc. LCI Full chart Compare Add to watchlist Set alert Price alert · LCI Alert when the price is Price abovePrice below Price level Set alert All alert types 0.69 +0.69 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly Revenue by Segment FY 2022FY 2021FY 2020FY 2019 Income Tax Benefit → Expenses: $2.30MCentral Nervous System → Revenue: $78.33MExpenses → Selling, General & Admin: $81.02MExpenses → Research & Development: $22.36MExpenses → Interest Expense: $57.98MExpenses → Other Expenses: $105.73MGross Profit → Expenses: $33.17MRevenue → Gross Profit: $33.17MRevenue → Cost of Revenue: $307.41MGastrointestinal → Revenue: $51.03MNet Loss → Expenses: $231.62MCardiovascular → Revenue: $45.38MOther → Revenue: $41.28MInfectious Disease → Revenue: $28.01MEndocrinology → Revenue: $27.49MOther → Revenue: $69.07MIncome Tax Benefit$2.30MGross Profit$33.17MNet Loss$231.62MCost of Revenue$307.41MExpenses$267.09MSelling, General & Admin$81.02MResearch & Development$22.36MInterest Expense$57.98MOther Expenses$105.73MRevenue$340.58MCentral Nervous System$78.33MGastrointestinal$51.03MCardiovascular$45.38MOther$41.28MInfectious Disease$28.01MEndocrinology$27.49MOther$69.07M No annual statement lines LCI has no annual lines for this statement.
